Source: biopharma didn't refuse 'Cures' pay-for; no one asked
This article was originally published in Scrip
Executive Summary
The Pharmaceutical Research and Manufacturers of America (PhRMA) has not turned up its nose at the idea of having drug makers help cover the costs of the 21st Century Cures Act – a major legislative initiative from the House Energy and Commerce Committee aimed at overhauling the US biomedical enterprise.